Benign prostatic hyperplasia (BPH) is the enlargement of the prostate gland in men. Situated around the urethra (tube that expels urine), the prostate gland can block the flow of urine as it enlarges causing urinary problems. The UroLift system is a minimally invasive surgical technique that treats urinary obstruction caused by BPH.

UroLift is made up of a delivery device and permanent implants. It involves the placement of these implants on the prostate with the help of the delivery device. The delivery system is introduced through the urethra under endoscopic guidance to reach the blocked area. The implants are introduced and permanently placed to hold the enlarged prostate tissue away from the urethra thereby decompressing it. The number of implants used depends on the degree of obstruction and the size of the prostate. The procedure does not involve cutting, heating, removal or damage to tissues, which can affect sexual function. The UroLift is an alternative to the transurethral resection of the prostate or TURP and is intended for men who wish to retain their quality of life and sexual function and avoid major surgery. However, the UroLift system may not be recommended if the prostate is too enlarged.